{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T20:17:02Z","timestamp":1793305022829,"version":"4.5.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Eleva GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03418-2","type":"journal-article","created":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T15:13:31Z","timestamp":1744384411000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degeneration"],"prefix":"10.1186","volume":"22","author":[{"given":"Mandy","family":"Hector","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena","family":"Behnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Dabrowska-Schlepp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Schaaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Langmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,11]]},"reference":[{"key":"3418_CR1","first-page":"353","volume":"58","author":"JZ Nowak","year":"2006","unstructured":"Nowak JZ. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep. 2006;58:353\u201363.","journal-title":"Pharmacol Rep"},{"key":"3418_CR2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.ophtha.2006.09.022","volume":"114","author":"U Chakravarthy","year":"2007","unstructured":"Chakravarthy U, Augood C, Bentham GC, de Jong PT, Rahu M, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Vingerling JR, et al. Cigarette smoking and age-related macular degeneration in the EUREYE Study. Ophthalmology. 2007;114:1157\u201363.","journal-title":"Ophthalmology"},{"key":"3418_CR3","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/ceo.13343","volume":"47","author":"NA Chapman","year":"2019","unstructured":"Chapman NA, Jacobs RJ, Braakhuis AJ. Role of diet and food intake in age-related macular degeneration: a systematic review. Clin Exp Ophthalmol. 2019;47:106\u201327.","journal-title":"Clin Exp Ophthalmol"},{"issue":"85\u201393","key":"3418_CR4","volume":"160","author":"AR Rudnicka","year":"2015","unstructured":"Rudnicka AR, Kapetanakis VV, Jarrar Z, Wathern AK, Wormald R, Fletcher AE, Cook DG, Owen CG. Incidence of late-stage age-related macular degeneration in American Whites: systematic review and meta-analysis. Am J Ophthalmol. 2015;160(85\u201393): e83.","journal-title":"Am J Ophthalmol"},{"key":"3418_CR5","doi-asserted-by":"publisher","first-page":"e8259","DOI":"10.15252\/emmm.201708259","volume":"10","author":"I Akhtar-Schafer","year":"2018","unstructured":"Akhtar-Schafer I, Wang L, Krohne TU, Xu H, Langmann T. Modulation of three key innate immune pathways for the most common retinal degenerative diseases. EMBO Mol Med. 2018;10:e8259.","journal-title":"EMBO Mol Med"},{"key":"3418_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL, Burdon KP, Hebbring SJ, Wen C, Gorski M, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48:134\u201343.","journal-title":"Nat Genet"},{"key":"3418_CR7","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.imbio.2010.05.010","volume":"215","author":"M Karlstetter","year":"2010","unstructured":"Karlstetter M, Ebert S, Langmann T. Microglia in the healthy and degenerating retina: insights from novel mouse models. Immunobiology. 2010;215:685\u201391.","journal-title":"Immunobiology"},{"key":"3418_CR8","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1189\/jlb.0207114","volume":"81","author":"T Langmann","year":"2007","unstructured":"Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol. 2007;81:1345\u201351.","journal-title":"J Leukoc Biol"},{"key":"3418_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101249","volume":"100","author":"M Hector","year":"2024","unstructured":"Hector M, Langmann T, Wolf A. Translocator protein (18 kDa) (Tspo) in the retina and implications for ocular diseases. Prog Retin Eye Res. 2024;100: 101249.","journal-title":"Prog Retin Eye Res"},{"key":"3418_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.preteyeres.2014.11.004","volume":"45","author":"M Karlstetter","year":"2015","unstructured":"Karlstetter M, Scholz R, Rutar M, Wong WT, Provis JM, Langmann T. Retinal microglia: Just bystander or target for therapy? Prog Retin Eye Res. 2015;45:30\u201357.","journal-title":"Prog Retin Eye Res"},{"key":"3418_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s12974-015-0431-4","volume":"12","author":"R Scholz","year":"2015","unstructured":"Scholz R, Sobotka M, Caramoy A, Stempfl T, Moehle C, Langmann T. Minocycline counter-regulates pro-inflammatory microglia responses in the retina and protects from degeneration. J Neuroinflammation. 2015;12:209.","journal-title":"J Neuroinflammation"},{"key":"3418_CR12","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.1038\/s41467-020-16400-8","volume":"11","author":"A Wolf","year":"2020","unstructured":"Wolf A, Herb M, Schramm M, Langmann T. The TSPO-NOX1 axis controls phagocyte-triggered pathological angiogenesis in the eye. Nat Commun. 2020;11:2709.","journal-title":"Nat Commun"},{"key":"3418_CR13","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.neuron.2012.03.026","volume":"74","author":"DP Schafer","year":"2012","unstructured":"Schafer DP, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Yamasaki R, Ransohoff RM, Greenberg ME, Barres BA, Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691\u2013705.","journal-title":"Neuron"},{"key":"3418_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev-vision-091517-034425","volume":"4","author":"SM Silverman","year":"2018","unstructured":"Silverman SM, Wong WT. Microglia in the retina: roles in development, maturity, and disease. Annu Rev Vis Sci. 2018;4:45\u201377.","journal-title":"Annu Rev Vis Sci"},{"key":"3418_CR15","first-page":"1588","volume":"17","author":"C Luo","year":"2011","unstructured":"Luo C, Chen M, Xu H. Complement gene expression and regulation in mouse retina and retinal pigment epithelium\/choroid. Mol Vis. 2011;17:1588\u201397.","journal-title":"Mol Vis"},{"key":"3418_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0093343","volume":"9","author":"M Rutar","year":"2014","unstructured":"Rutar M, Valter K, Natoli R, Provis JM. Synthesis and propagation of complement C3 by microglia\/monocytes in the aging retina. PLoS ONE. 2014;9: e93343.","journal-title":"PLoS ONE"},{"key":"3418_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00441-010-1034-0","volume":"343","author":"JV Sarma","year":"2011","unstructured":"Sarma JV, Ward PA. The complement system. Cell Tissue Res. 2011;343:227\u201335.","journal-title":"Cell Tissue Res"},{"key":"3418_CR18","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.imbio.2012.07.008","volume":"217","author":"B Nilsson","year":"2012","unstructured":"Nilsson B, Nilsson Ekdahl K. The tick-over theory revisited: is C3 a contact-activated protein? Immunobiology. 2012;217:1106\u201310.","journal-title":"Immunobiology"},{"key":"3418_CR19","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/imr.13130","volume":"313","author":"MK Pangburn","year":"2023","unstructured":"Pangburn MK. Initiation of the alternative pathway of complement and the history of \u201ctickover.\u201d Immunol Rev. 2023;313:64\u201370.","journal-title":"Immunol Rev"},{"key":"3418_CR20","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.molimm.2016.11.016","volume":"84","author":"MJ Geerlings","year":"2017","unstructured":"Geerlings MJ, de Jong EK, den Hollander AI. The complement system in age-related macular degeneration: a review of rare genetic variants and implications for personalized treatment. Mol Immunol. 2017;84:65\u201376.","journal-title":"Mol Immunol"},{"key":"3418_CR21","doi-asserted-by":"publisher","first-page":"602284","DOI":"10.3389\/fimmu.2020.602284","volume":"11","author":"EKS Wong","year":"2021","unstructured":"Wong EKS, Hallam TM, Brocklebank V, Walsh PR, Smith-Jackson K, Shuttleworth VG, Cox TE, Anderson HE, Barlow PN, Marchbank KJ, et al. Functional characterization of rare genetic variants in the N-terminus of complement factor H in aHUS, C3G, and AMD. Front Immunol. 2021;11:602284.","journal-title":"Front Immunol"},{"key":"3418_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00281-017-0663-8","volume":"40","author":"EKS Wong","year":"2018","unstructured":"Wong EKS, Kavanagh D. Diseases of complement dysregulation\u2014an overview. Seminars in Immunopathology. 2018;40:49\u201364.","journal-title":"Seminars in Immunopathology"},{"key":"3418_CR23","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1126\/science.1110189","volume":"308","author":"AO Edwards","year":"2005","unstructured":"Edwards AO, Ritter R 3rd, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421\u20134.","journal-title":"Science"},{"key":"3418_CR24","doi-asserted-by":"publisher","first-page":"7227","DOI":"10.1073\/pnas.0501536102","volume":"102","author":"GS Hageman","year":"2005","unstructured":"Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, Hageman JL, Stockman HA, Borchardt JD, Gehrs KM, et al. A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA. 2005;102:7227\u201332.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3418_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1126\/science.1110359","volume":"308","author":"JL Haines","year":"2005","unstructured":"Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, Spencer KL, Kwan SY, Noureddine M, Gilbert JR, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419\u201321.","journal-title":"Science"},{"key":"3418_CR26","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1126\/science.1109557","volume":"308","author":"RJ Klein","year":"2005","unstructured":"Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385\u20139.","journal-title":"Science"},{"key":"3418_CR27","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/ng.976","volume":"43","author":"S Raychaudhuri","year":"2011","unstructured":"Raychaudhuri S, Iartchouk O, Chin K, Tan PL, Tai AK, Ripke S, Gowrisankar S, Vemuri S, Montgomery K, Yu Y, et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet. 2011;43:1232\u20136.","journal-title":"Nat Genet"},{"key":"3418_CR28","doi-asserted-by":"publisher","first-page":"5283","DOI":"10.1093\/hmg\/ddu226","volume":"23","author":"Y Yu","year":"2014","unstructured":"Yu Y, Triebwasser MP, Wong EKS, Schramm EC, Thomas B, Reynolds R, Mardis ER, Atkinson JP, Daly M, Raychaudhuri S, et al. Whole-exome sequencing identifies rare, functional CFH variants in families with macular degeneration. Hum Mol Genet. 2014;23:5283\u201393.","journal-title":"Hum Mol Genet"},{"key":"3418_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ejhg.2008.140","volume":"17","author":"JA Fagerness","year":"2009","unstructured":"Fagerness JA, Maller JB, Neale BM, Reynolds RC, Daly MJ, Seddon JM. Variation near complement factor I is associated with risk of advanced AMD. Eur J Hum Genet. 2009;17:100\u20134.","journal-title":"Eur J Hum Genet"},{"key":"3418_CR30","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1038\/ng.2740","volume":"45","author":"H Helgason","year":"2013","unstructured":"Helgason H, Sulem P, Duvvari MR, Luo H, Thorleifsson G, Stefansson H, Jonsdottir I, Masson G, Gudbjartsson DF, Walters GB, et al. A rare nonsynonymous sequence variant in C3 is associated with high risk of age-related macular degeneration. Nat Genet. 2013;45:1371\u20134.","journal-title":"Nat Genet"},{"key":"3418_CR31","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1038\/ng.2741","volume":"45","author":"JM Seddon","year":"2013","unstructured":"Seddon JM, Yu Y, Miller EC, Reynolds R, Tan PL, Gowrisankar S, Goldstein JI, Triebwasser M, Anderson HE, Zerbib J, et al. Rare variants in CFI, C3 and C9 are associated with high risk of advanced age-related macular degeneration. Nat Genet. 2013;45:1366\u201370.","journal-title":"Nat Genet"},{"key":"3418_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/ng.2640","volume":"45","author":"JP van de Ven","year":"2013","unstructured":"van de Ven JP, Nilsson SC, Tan PL, Buitendijk GH, Ristau T, Mohlin FC, Nabuurs SB, Schoenmaker-Koller FE, Smailhodzic D, Campochiaro PA, et al. A functional variant in the CFI gene confers a high risk of age-related macular degeneration. Nat Genet. 2013;45:813\u20137.","journal-title":"Nat Genet"},{"key":"3418_CR33","doi-asserted-by":"publisher","first-page":"103757","DOI":"10.1016\/j.drudis.2023.103757","volume":"28","author":"S Rathi","year":"2023","unstructured":"Rathi S, Hasan R, Ueffing M, Clark SJ. Therapeutic targeting of the complement system in ocular disease. Drug Discov Today. 2023;28:103757.","journal-title":"Drug Discov Today"},{"key":"3418_CR34","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1016\/S0140-6736(23)01583-0","volume":"402","author":"AM Khanani","year":"2023","unstructured":"Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, et al. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet. 2023;402:1449\u201358.","journal-title":"Lancet"},{"key":"3418_CR35","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ajo.2021.02.031","volume":"227","author":"NC Steinle","year":"2021","unstructured":"Steinle NC, Pearce I, Mones J, Metlapally R, Saroj N, Hamdani M, Ribeiro R, Rosenfeld PJ, Lad EM. Impact of baseline characteristics on geographic atrophy progression in the FILLY trial evaluating the complement C3 inhibitor pegcetacoplan. Am J Ophthalmol. 2021;227:116\u201324.","journal-title":"Am J Ophthalmol"},{"key":"3418_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.13166","volume":"313","author":"L Lucientes-Continente","year":"2023","unstructured":"Lucientes-Continente L, Marquez-Tirado B, Goicoechea de Jorge E. The Factor H protein family: the switchers of the complement alternative pathway. Immunol Rev. 2023;313:25\u201345.","journal-title":"Immunol Rev"},{"key":"3418_CR37","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ki.2010.132","volume":"78","author":"F Fakhouri","year":"2010","unstructured":"Fakhouri F, de Jorge EG, Brune F, Azam P, Cook HT, Pickering MC. Treatment with human complement factor H rapidly reverses renal complement deposition in factor H-deficient mice. Kidney Int. 2010;78:279\u201386.","journal-title":"Kidney Int"},{"key":"3418_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12974-024-03045-3","volume":"21","author":"J Biber","year":"2024","unstructured":"Biber J, Jabri Y, Glanzer S, Dort A, Hoffelner P, Schmidt CQ, Bludau O, Pauly D, Grosche A. Gliosis-dependent expression of complement factor H truncated variants attenuates retinal neurodegeneration following ischemic injury. J Neuroinflammation. 2024;21:56.","journal-title":"J Neuroinflammation"},{"key":"3418_CR39","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/02713683.2022.2053725","volume":"47","author":"RM Biggs","year":"2022","unstructured":"Biggs RM, Makou E, Lauder S, Herbert AP, Barlow PN, Katti SK. A novel full-length recombinant human complement factor H (CFH; GEM103) for the treatment of age-related macular degeneration shows similar functional activity to native CFH. Curr Eye Res. 2022;47:1087\u201393.","journal-title":"Curr Eye Res"},{"key":"3418_CR40","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1681\/ASN.2015070745","volume":"28","author":"S Michelfelder","year":"2017","unstructured":"Michelfelder S, Parsons J, Bohlender LL, Hoernstein SNW, Niederkr\u00fcger H, Busch A, Krieghoff N, Koch J, Fode B, Schaaf A, et al. Moss-produced, glycosylation-optimized human factor H for therapeutic application in complement disorders. J Am Soc Nephrol. 2017;28:1462\u201374.","journal-title":"J Am Soc Nephrol"},{"key":"3418_CR41","doi-asserted-by":"publisher","first-page":"5503","DOI":"10.2174\/1381612811319310006","volume":"19","author":"D Bosch","year":"2013","unstructured":"Bosch D, Castilho A, Loos A, Schots A, Steinkellner H. N-Glycosylation of plant-produced recombinant proteins. Curr Pharm Des. 2013;19:5503\u201312.","journal-title":"Curr Pharm Des"},{"key":"3418_CR42","doi-asserted-by":"publisher","first-page":"1383123","DOI":"10.3389\/fimmu.2024.1383123","volume":"15","author":"TKS Tschongov","year":"2024","unstructured":"Tschongov TKS, Busch A, Sievert C, Hartmann A, Noris M, Gastoldi S, Aiello S, Schaaf A, Panse J, Zipfel P, Dabrowska-Schlepp P, H\u00e4ffner K. Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activity. Front Immunol. 2024;15:1383123.","journal-title":"Front Immunol"},{"key":"3418_CR43","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-62703-080-9_6","volume":"935","author":"C Grimm","year":"2013","unstructured":"Grimm C, Reme CE. Light damage as a model of retinal degeneration. Methods Mol Biol. 2013;935:87\u201397.","journal-title":"Methods Mol Biol"},{"key":"3418_CR44","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.bbrc.2016.12.141","volume":"483","author":"A Wolf","year":"2017","unstructured":"Wolf A, Aslanidis A, Langmann T. Retinal expression and localization of Mef2c support its important role in photoreceptor gene expression. Biochem Biophys Res Commun. 2017;483:346\u201351.","journal-title":"Biochem Biophys Res Commun"},{"key":"3418_CR45","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12974-019-1419-2","volume":"16","author":"C Balser","year":"2019","unstructured":"Balser C, Wolf A, Herb M, Langmann T. Co-inhibition of PGF and VEGF blocks their expression in mononuclear phagocytes and limits neovascularization and leakage in the murine retina. J Neuroinflammation. 2019;16:26.","journal-title":"J Neuroinflammation"},{"key":"3418_CR46","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.immuni.2019.02.007","volume":"50","author":"EG O'Koren","year":"2019","unstructured":"O\u2019Koren EG, Yu C, Klingeborn M, Wong AYW, Prigge CL, Mathew R, Kalnitsky J, Msallam RA, Silvin A, Kay JN, et al. Microglial function is distinct in different anatomical locations during retinal homeostasis and degeneration. Immunity. 2019;50:723.","journal-title":"Immunity"},{"key":"3418_CR47","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1007\/s00467-015-3111-9","volume":"30","author":"K Haffner","year":"2015","unstructured":"Haffner K, Michelfelder S, Pohl M. Successful therapy of C3Nef-positive C3 glomerulopathy with plasma therapy and immunosuppression. Pediatr Nephrol. 2015;30:1951\u20139.","journal-title":"Pediatr Nephrol"},{"key":"3418_CR48","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.ki.5000269","volume":"70","author":"C Licht","year":"2006","unstructured":"Licht C, Heinen S, Jozsi M, Loschmann I, Saunders RE, Perkins SJ, Waldherr R, Skerka C, Kirschfink M, Hoppe B, et al. Deletion of Lys224 in regulatory domain 4 of Factor H reveals a novel pathomechanism for dense deposit disease (MPGN II). Kidney Int. 2006;70:42\u201350.","journal-title":"Kidney Int"},{"key":"3418_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.566892","volume":"11","author":"DM Borucki","year":"2020","unstructured":"Borucki DM, Toutonji A, Couch C, Mallah K, Rohrer B, Tomlinson S. Complement-mediated microglial phagocytosis and pathological changes in the development and degeneration of the visual system. Front Immunol. 2020;11: 566892.","journal-title":"Front Immunol"},{"key":"3418_CR50","first-page":"210","volume":"23","author":"D Song","year":"2017","unstructured":"Song D, Sulewski ME Jr, Wang C, Song J, Bhuyan R, Sterling J, Clark E, Song WC, Dunaief JL. Complement C5a receptor knockout has diminished light-induced microglia\/macrophage retinal migration. Mol Vis. 2017;23:210\u20138.","journal-title":"Mol Vis"},{"key":"3418_CR51","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.3389\/fimmu.2018.02701","volume":"9","author":"E Nissil\u00e4","year":"2018","unstructured":"Nissil\u00e4 E, Hakala P, Leskinen K, Roig A, Syed S, Van Kessel KPM, Metso J, De Haas CJC, Saavalainen P, Meri S, et al. Complement factor H and apolipoprotein E participate in regulation of inflammation in THP-1 macrophages. Front Immunol. 2018;9:2701.","journal-title":"Front Immunol"},{"key":"3418_CR52","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.immuni.2017.01.006","volume":"46","author":"B Calippe","year":"2017","unstructured":"Calippe B, Augustin S, Beguier F, Charles-Messance H, Poupel L, Conart J-B, Hu SJ, Lavalette S, Fauvet A, Rayes J, et al. Complement factor H inhibits CD47-mediated resolution of inflammation. Immunity. 2017;46:261\u201372.","journal-title":"Immunity"},{"key":"3418_CR53","first-page":"100866","volume":"24","author":"V Behnke","year":"2020","unstructured":"Behnke V, Langmann T. IFN-\u03b2 signaling dampens microglia reactivity but does not prevent from light-induced retinal degeneration. Biochem Biophys Rep. 2020;24:100866.","journal-title":"Biochem Biophys Rep"},{"key":"3418_CR54","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3389\/fnmol.2017.00197","volume":"10","author":"N Sch\u00e4fer","year":"2017","unstructured":"Sch\u00e4fer N, Grosche A, Schmitt SI, Braunger BM, Pauly D. Complement components showed a time-dependent local expression pattern in constant and acute white light-induced photoreceptor damage. Front Mol Neurosci. 2017;10:197.","journal-title":"Front Mol Neurosci"},{"key":"3418_CR55","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12974-022-02589-6","volume":"19","author":"M Tabel","year":"2022","unstructured":"Tabel M, Wolf A, Szczepan M, Xu H, Jagle H, Moehle C, Chen M, Langmann T. Genetic targeting or pharmacological inhibition of galectin-3 dampens microglia reactivity and delays retinal degeneration. J Neuroinflammation. 2022;19:229.","journal-title":"J Neuroinflammation"},{"key":"3418_CR56","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/cdd.2015.164","volume":"23","author":"M Martin","year":"2016","unstructured":"Martin M, Leffler J, Smolag KI, Mytych J, Bjork A, Chaves LD, Alexander JJ, Quigg RJ, Blom AM. Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes. Cell Death Differ. 2016;23:903\u201311.","journal-title":"Cell Death Differ"},{"key":"3418_CR57","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/1521-4141(200203)32:3<783::AID-IMMU783>3.0.CO;2-Q","volume":"32","author":"Nauta AJ, Daha MR, Tijsma O, van de Water B, Tedesco F, Roos A","year":"2002","unstructured":"Nauta AJ, Daha MR, Tijsma O, van de Water B, Tedesco F, Roos A. The membrane attack complex of complement induces caspase activation and apoptosis. Eur J Immunol. 2002;32:783\u201392.","journal-title":"Eur J Immunol"},{"key":"3418_CR58","doi-asserted-by":"publisher","first-page":"8108","DOI":"10.1167\/iovs.10-6418","volume":"52","author":"RJ Collier","year":"2011","unstructured":"Collier RJ, Wang Y, Smith SS, Martin E, Ornberg R, Rhoades K, Romano C. Complement deposition and microglial activation in the outer retina in light-induced retinopathy: inhibition by a 5-HT1A agonist. Invest Opthalmol Vis Sci. 2011;52:8108\u201316.","journal-title":"Invest Opthalmol Vis Sci"},{"key":"3418_CR59","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1136\/bjophthalmol-2012-302307","volume":"97","author":"SJ Kim","year":"2013","unstructured":"Kim SJ, Kim J, Lee J, Cho SY, Kang HJ, Kim KY, Jin DK. Intravitreal human complement factor H in a rat model of laser-induced choroidal neovascularisation. Brit J Ophthalmol. 2013;97:367\u201370.","journal-title":"Brit J Ophthalmol"},{"key":"3418_CR60","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.2353\/ajpath.2010.091168","volume":"177","author":"VV Lyzogubov","year":"2010","unstructured":"Lyzogubov VV, Tytarenko RG, Jha P, Liu JA, Bora NS, Bora PS. Role of ocular complement factor H in a murine model of choroidal neovascularization. Am J Pathol. 2010;177:1870\u201380.","journal-title":"Am J Pathol"},{"key":"3418_CR61","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0142-9612(00)00193-9","volume":"22","author":"FM Veronese","year":"2001","unstructured":"Veronese FM. Peptide and protein PEGylation: a review of problems and solutions. Biomaterials. 2001;22:405\u201317.","journal-title":"Biomaterials"},{"key":"3418_CR62","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1248\/bpb.b13-00661","volume":"37","author":"F Zhang","year":"2014","unstructured":"Zhang F, Liu MR, Wan HT. Discussion about several potential drawbacks of PEGylated therapeutic proteins. Biol Pharm Bull. 2014;37:335\u20139.","journal-title":"Biol Pharm Bull"},{"key":"3418_CR63","doi-asserted-by":"publisher","first-page":"16229","DOI":"10.1074\/jbc.M110.204701","volume":"286","author":"VV Lyzogubov","year":"2011","unstructured":"Lyzogubov VV, Tytarenko RG, Liu J, Bora NS, Bora PS. Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization. J Biol Chem. 2011;286:16229\u201337.","journal-title":"J Biol Chem"},{"key":"3418_CR64","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","volume":"128","author":"GJ Jaffe","year":"2021","unstructured":"Jaffe GJ, Westby K, Csaky KG, Mon\u00e9s J, Pearlman JA, Patel SS, Joondeph BC, Randolph J, Masonson H, Rezaei KA. C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration. Ophthalmology. 2021;128:576\u201386.","journal-title":"Ophthalmology"},{"key":"3418_CR65","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","volume":"127","author":"DS Liao","year":"2020","unstructured":"Liao DS, Grossi FV, El Mehdi D, Gerber MR, Brown DM, Heier JS, Wykoff CC, Singerman LJ, Abraham P, Grassmann F, et al. Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration. Ophthalmology. 2020;127:186\u201395.","journal-title":"Ophthalmology"},{"key":"3418_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2022.100154","volume":"2","author":"AM Khanani","year":"2022","unstructured":"Khanani AM, Maturi RK, Bagheri N, Bakall B, Boyer DS, Couvillion SS, Dhoot DS, Holekamp NM, Jamal KN, Marcus DM, et al. A phase I, single ascending dose study of GEM103 (recombinant human complement factor H) in patients with geographic atrophy. Ophthalmol Sci. 2022;2: 100154.","journal-title":"Ophthalmol Sci"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03418-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03418-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03418-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T17:09:01Z","timestamp":1744391341000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-025-03418-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,11]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3418"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03418-2","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,11]]},"assertion":[{"value":"22 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were reviewed and approved by the government office responsible for animal welfare in North-Rhine-Westphalia (Landesamt f\u00fcr Natur, Umwelt und Verbraucherschutz, Application No. 81-02.04.2021.A277). All experimental procedures complied with the German law on animal protection and the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Paulina Dabrowska-Schlepp, Andreas Busch and Andreas Schaaf are employees of Eleva GmbH and are co-authors of a patent for recombinant CFH (CPV-104).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests\u00a0"}}],"article-number":"104"}}